Multiple Sclerosis

Multiple Sclerosis News

  • CMSC CMSC 2017: All About Teamwork in MS A team approach to multiple sclerosis is the overarching theme of this year's Consortium of Multiple Sclerosis Centers annual meeting, celebrating its 31st anniversary.
  • AAN Ocrelizumab Benefits Early and 'Quite Persistent' in MS Pooled data from the OPERA studies show that onset of efficacy occurred within 8 weeks for patients receiving ocrelizumab, while preliminary results from its extension phase show continued benefit.
 

Multiple Sclerosis Perspective

 

Journals